Conduit Pharmaceuticals (CDT) Short Interest Ratio & Short Volume

Short interest is the volume of Conduit Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 3,570,000 shares of CDT short. Learn More on Conduit Pharmaceuticals' current short interest.

Conduit Pharmaceuticals saw a decrease in short interest in October. As of October 31st, there was short interest totaling 3,570,000 shares, a decrease of 23.2% from the previous total of 4,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Conduit Pharmaceuticals: Barinthus Biotherapeutics plc (0.02%), OKYO Pharma Limited (1.11%), Citius Pharmaceuticals, Inc. (6.52%), Lexaria Bioscience Corp. (1.72%), Elevation Oncology, Inc. (12.42%), Lantern Pharma Inc. (2.06%), Surrozen, Inc. (1.47%), ProMIS Neurosciences, Inc. (1.16%), ImmuCell Co. (0.09%), Acasti Pharma Inc. (2.47%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling CDT is an investing strategy that aims to generate trading profit from Conduit Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Conduit Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CDT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDT, twice per month. The most recent reporting period available is October, 31 2024.